KRAS and ovarian cancer: The results show that ovarian cancer in the high-risk group may be involved in epithelial-mesenchymal transition, KRAS signaling pathway, TNF NFKB signaling pathway, and angiogenesis, while the low-risk group is negatively associated with E2F and MYC pathways.